HLSC-Islets

N/A

Report date: 2025/03/20 15:14:41

Base Information

Drug NameHLSC-Islets
Drug Alias Namehuman liver stem cell-derived islet therapy (University of Turin/Unicyte)human liver stem cell-derived islet therapy (University of Turin/Fresenius Medical Care)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Pancreagenic potential stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyGermanySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Torino
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of TorinoUnicyte SRL
Inactive CompaniesFresenius Se & Co. Kgaa
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A